Clinical Trial: Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07308717) titled 'Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol' on Dec. 17.

Brief Summary: This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Study Start Date: Dec. 16

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: OTHER: Modification to Pre-operative Order Set

Modification to the pre-operative order set to remove gabapentin

Recruitment Status: RECRUITING

Sponsor: Memorial Sloan Kettering Cancer Center

Disclaimer: Curated by HT Syndication....